These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4556296)

  • 21. Studies on the uptake and subcellular distribution of catecholamines and their alpha-methylated analogues.
    Lundborg P
    Acta Physiol Scand Suppl; 1967; 302():1-34. PubMed ID: 5584149
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of methylguanidine on norepinephrine metabolism in isolated, perfused spleen and heart.
    Cubeddu L; Mosimann W; Weiner N
    J Pharmacol Exp Ther; 1974 Jan; 188(1):93-106. PubMed ID: 4809281
    [No Abstract]   [Full Text] [Related]  

  • 23. Differential effects of monoamine oxidase inhibitors.
    Maickel RP; Rompalo AM; Cox RH
    Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):727-30. PubMed ID: 4420181
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibition of MAO B, but not MAO A, blocks DSP-4 toxicity on central NE neurons.
    Gibson CJ
    Eur J Pharmacol; 1987 Sep; 141(1):135-8. PubMed ID: 3117577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.
    Green AR; Mitchell BD; Tordoff AF; Youdim MB
    Br J Pharmacol; 1977 Jul; 60(3):343-9. PubMed ID: 890205
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of aminoacetonitrile, an amine oxidase inhibitor, on mescaline metabolism in the rabbit.
    Riceberg LJ; Simon M; Van Vunakis H; Abeles RH
    Biochem Pharmacol; 1975 Jan; 24(1):119-25. PubMed ID: 1168468
    [No Abstract]   [Full Text] [Related]  

  • 27. The effects of perturbation of cerebral amine metabolism on operationally defined learning and memory processes of goldfish.
    Stahl SM; Narotzky RA; Boshes B; Zeller EA
    Biol Psychiatry; 1974 Dec; 9(3):295-323. PubMed ID: 4441577
    [No Abstract]   [Full Text] [Related]  

  • 28. The action of neuroleptics in rats with altered catecholamine metabolism. II. The effects of chlorpromazine, haloperidol, and thioridazine on brain noradrenaline content elevated by previous administration of MAO inhibitors.
    Vetulani J
    Pol J Pharmacol Pharm; 1973; 25(1):53-64. PubMed ID: 4775864
    [No Abstract]   [Full Text] [Related]  

  • 29. On the selective inhibition by some monoamine oxidase inhibitors of deamination of biogenic monoamines in vivo.
    Gorkin VZ; Romanova LA
    Biochem Pharmacol; 1968 Jun; 17(6):855-60. PubMed ID: 5661349
    [No Abstract]   [Full Text] [Related]  

  • 30. Distribution and metabolism of tryptamine in rat brain.
    Wu PH; Boulton AA
    Can J Biochem; 1973 Jul; 51(7):1104-12. PubMed ID: 4725358
    [No Abstract]   [Full Text] [Related]  

  • 31. [Modification of the metabolism of cerebral serotonin (5-HT) induced in rats by the administration of 6-hydroxydopamine].
    Blondaux C; Juge A; Sordet F; Chouvet G; Jouvet M; Pujol JF
    Brain Res; 1973 Feb; 50(1):101-14. PubMed ID: 4690541
    [No Abstract]   [Full Text] [Related]  

  • 32. Proceedings: Hydrocortisone-induced supersensitivity to noradrenaline in the isolated nictitating membrane as a consequence of an impairment of an O-methylating system with high affinity.
    Graefe KH; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R26. PubMed ID: 4276550
    [No Abstract]   [Full Text] [Related]  

  • 33. The effects of pargyline on overflow of transmitter and uptake of noradrenaline in the cat spleen.
    Blakeley AG; Powis G; Summers RJ
    Br J Pharmacol; 1973 Apr; 47(4):719-28. PubMed ID: 4353241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of chlordimeform and clonidine on the turnover of P-octopamine in rat hypothalamus and striatum.
    Duffield PH; Dougan DF; Wade DN; Duffield AM
    Life Sci; 1986 Apr; 38(14):1271-80. PubMed ID: 3083168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of release of alpha-methylated noradrenaline analogues by monoamine oxidase inhibitors.
    Carlsson A; Lindqvist M; Waldeck B
    Eur J Pharmacol; 1968 Apr; 3(1):34-9. PubMed ID: 5654667
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug-induced modification of ( 3 H)-histamine catabolism in the rat hypothalamus in vivo.
    Akin FJ; Tobia AJ
    Res Commun Chem Pathol Pharmacol; 1972 Jan; 3(1):15-28. PubMed ID: 4555454
    [No Abstract]   [Full Text] [Related]  

  • 37. P-chloroamphetamine: in vivo investigations on the mechanism of action of the selective depletion of cerebral serotonin.
    Sanders-Bush E; Sulser F
    J Pharmacol Exp Ther; 1970 Nov; 175(2):419-26. PubMed ID: 5312363
    [No Abstract]   [Full Text] [Related]  

  • 38. [Histochemical study of the effect of drugs on the uptake of alpha-methylnoradrenaline by noradrenaline and dopamine containing neurones in rats treated with reserpine].
    Lorez HP
    Z Gesamte Exp Med Einschl Exp Chir; 1969; 151(3):241-60. PubMed ID: 5358460
    [No Abstract]   [Full Text] [Related]  

  • 39. Monoamine oxidase and catechol O-methyl transferase inhibitors. Effect of intradermal injection on exogenous and endogenous norepinephrine.
    DEOREO GA; STOUGHTON RB
    Arch Dermatol; 1961 Dec; 84():972-9. PubMed ID: 13885511
    [No Abstract]   [Full Text] [Related]  

  • 40. The relationships between alpha receptor block, inhibition of norepinephrine uptake and the release and metabolism of 3H-norepinephrine.
    Cubeddu L; Langer SZ; Weiner N
    J Pharmacol Exp Ther; 1974 Feb; 188(2):368-85. PubMed ID: 4149463
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.